Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT01802268
Eligibility Criteria:
Inclusion Criteria:
* patients older than 18 years,
* recipients of first kidney transplant from brain dead deceased or living related non-HLA identical donors not older than 65 years,
* patients had to receive an ABO compatible organ with a CDC negative crossmatch and a peak panel reactive antibody lower that 30%,
* all patients agreed to use contraceptive methods during the study and up to 3 months after study drug discontinuation.
Exclusion Criteria:
* patients with chronic kidney diseases due to focal and segmental glomerulosclerosis and membranoproliferative glomerulonephritis,
* patients with active infection or positive for hepatitis B or C or human immunodeficiency viruses,
* patients with previous history of malignancy,
* patients with significant hematological or metabolic laboratorial abnormalities.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01802268
Study Brief:
Protocol Section:
NCT01802268